At Altamont Pharma, our focus is to invest in small cap, publicly traded Biotech companies with an emphasis on Private Investment in Public Equity (PIPE) offerings. We partner with companies at any stage of the business life-cycle — pre-IND (Investigational New Drug) to post-NDA (New Drug Application) — and in any business activity — drug research, medical device, and information technology based products or services for the health care sector. Altamont Pharma's philosophy is to invest in the vision of the entrepreneurs and scientists striving to make the world a healthy place by curing life threatening diseases and reducing the debilitating effects of chronic disease. We understand that any innovative product or the new idea takes not only capital but also time, effort and expertise. We are in for the long-term and are happy to be involved in a company's strategy and operations.